$ABBV stock has now fallen 3% today, according to our price data from Polygon. There has been approximately $606,785,590 of trading volume.
It has been the 184th most-searched ticker on Quiver Quantitative over the last day, out of 10,455 total tickers searched.
Here is what we see in our data on $ABBV (you can track the company live on Quiver's $ABBV stock page):
$ABBV Insider Trading Activity
$ABBV insiders have traded $ABBV stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $ABBV stock by insiders over the last 6 months:
- AZITA SALEKI-GERHARDT (EVP, CHIEF OPERATIONS OFFICER) sold 42,370 shares for an estimated $8,407,055
- NICHOLAS DONOGHOE (EVP, CHIEF BUS/STRAT OFFICER) has made 0 purchases and 2 sales selling 13,295 shares for an estimated $2,639,252.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ABBV Hedge Fund Activity
We have seen 1,928 institutional investors add shares of $ABBV stock to their portfolio, and 1,655 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 10,559,645 shares (+72.3%) to their portfolio in Q3 2025, for an estimated $2,444,980,203
- WELLINGTON MANAGEMENT GROUP LLP added 8,646,424 shares (+457.4%) to their portfolio in Q3 2025, for an estimated $2,001,993,012
- KINGSTONE CAPITAL PARTNERS TEXAS, LLC removed 3,134,454 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $725,751,479
- CAPITAL INTERNATIONAL INVESTORS removed 2,947,890 shares (-21.6%) from their portfolio in Q3 2025, for an estimated $682,554,450
- NORGES BANK removed 1,992,983 shares (-7.9%) from their portfolio in Q2 2025, for an estimated $369,937,504
- QUBE RESEARCH & TECHNOLOGIES LTD removed 1,830,775 shares (-53.6%) from their portfolio in Q3 2025, for an estimated $423,897,643
- DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN added 1,771,612 shares (+37.5%) to their portfolio in Q3 2025, for an estimated $410,199,042
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ABBV Government Contracts
We have seen $390,623 of award payments to $ABBV over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- IMPLANT: $35,788
- 4567253744!NATRELLE TE SMOOTH 133S-SV-13-T: $33,629
- PROSTHETIC ORDER - IMPLANT ITEMS: $15,758
- PROSTHETIC ORDER - BREAST IMPLANTS: $14,124
- 4567881995!NATRELLE TE SMOOTH 133S-MV-15-T: $13,170
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$ABBV Congressional Stock Trading
Members of Congress have traded $ABBV stock 12 times in the past 6 months. Of those trades, 4 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $ABBV stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 11/13, 08/14.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 6 times. They made 3 purchases worth up to $45,000 on 10/30, 07/22, 06/17 and 3 sales worth up to $45,000 on 10/31, 10/30, 07/22.
- SENATOR JOHN BOOZMAN has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 08/22, 08/11.
- REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 08/04.
- REPRESENTATIVE RITCHIE TORRES sold up to $15,000 on 07/11.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$ABBV Analyst Ratings
Wall Street analysts have issued reports on $ABBV in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HSBC issued a "Buy" rating on 12/10/2025
- Guggenheim issued a "Buy" rating on 10/20/2025
- Piper Sandler issued a "Overweight" rating on 10/10/2025
- Cantor Fitzgerald issued a "Overweight" rating on 09/15/2025
- BMO Capital issued a "Outperform" rating on 09/12/2025
To track analyst ratings and price targets for $ABBV, check out Quiver Quantitative's $ABBV forecast page.
$ABBV Price Targets
Multiple analysts have issued price targets for $ABBV recently. We have seen 15 analysts offer price targets for $ABBV in the last 6 months, with a median target of $251.0.
Here are some recent targets:
- Terence Flynn from Morgan Stanley set a target price of $269.0 on 12/12/2025
- Rajesh Kumar from HSBC set a target price of $265.0 on 12/10/2025
- Ashwani Verma from UBS set a target price of $220.0 on 11/07/2025
- David Amsellem from Piper Sandler set a target price of $289.0 on 11/05/2025
- Chris Schott from JP Morgan set a target price of $260.0 on 11/03/2025
- Geoff Meacham from Citigroup set a target price of $235.0 on 11/03/2025
- Vamil Divan from Guggenheim set a target price of $242.0 on 10/20/2025
You can track data on $ABBV on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
